These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 31791173)
41. N+1 Engineering of an Aspartate Isomerization Hotspot in the Complementarity-Determining Region of a Monoclonal Antibody. Patel CN; Bauer SP; Davies J; Durbin JD; Shiyanova TL; Zhang K; Tang JX J Pharm Sci; 2016 Feb; 105(2):512-518. PubMed ID: 26869414 [TBL] [Abstract][Full Text] [Related]
42. Molecular Characterization of Two Monoclonal Antibodies against the Same Epitope on B-Cell Receptor Associated Protein 31. Kim WT; Shin S; Hwang HJ; Kim MK; Jung HS; Park H; Ryu CJ PLoS One; 2016; 11(12):e0167527. PubMed ID: 27907150 [TBL] [Abstract][Full Text] [Related]
43. Roles of the respective loops at complementarity determining region on the antigen-antibody recognition. Osajima T; Hoshino T Comput Biol Chem; 2016 Oct; 64():368-383. PubMed ID: 27591792 [TBL] [Abstract][Full Text] [Related]
46. Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120. Zwick MB; Parren PW; Saphire EO; Church S; Wang M; Scott JK; Dawson PE; Wilson IA; Burton DR J Virol; 2003 May; 77(10):5863-76. PubMed ID: 12719580 [TBL] [Abstract][Full Text] [Related]
47. Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1. Gohain N; Tolbert WD; Acharya P; Yu L; Liu T; Zhao P; Orlandi C; Visciano ML; Kamin-Lewis R; Sajadi MM; Martin L; Robinson JE; Kwong PD; DeVico AL; Ray K; Lewis GK; Pazgier M J Virol; 2015 Sep; 89(17):8840-54. PubMed ID: 26085162 [TBL] [Abstract][Full Text] [Related]
48. Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody. Tudor D; Yu H; Maupetit J; Drillet AS; Bouceba T; Schwartz-Cornil I; Lopalco L; Tuffery P; Bomsel M Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12680-5. PubMed ID: 22723360 [TBL] [Abstract][Full Text] [Related]
49. Computational design of protein antigens that interact with the CDR H3 loop of HIV broadly neutralizing antibody 2F5. Azoitei ML; Ban YA; Kalyuzhny O; Guenaga J; Schroeter A; Porter J; Wyatt R; Schief WR Proteins; 2014 Oct; 82(10):2770-82. PubMed ID: 25043744 [TBL] [Abstract][Full Text] [Related]
50. Analysis of a 17-amino acid residue, virus-neutralizing microantibody. Heap CJ; Wang Y; Pinheiro TJT; Reading SA; Jennings KR; Dimmock NJ J Gen Virol; 2005 Jun; 86(Pt 6):1791-1800. PubMed ID: 15914858 [TBL] [Abstract][Full Text] [Related]
51. The mechanism of cis-trans isomerization of prolyl peptides by cyclophilin. Hur S; Bruice TC J Am Chem Soc; 2002 Jun; 124(25):7303-13. PubMed ID: 12071739 [TBL] [Abstract][Full Text] [Related]
52. Recombinant antibodies with conformationally constrained HIV type 1 epitope inserts elicit glycoprotein 160-specific antibody responses in vivo. Cook J; Barber BH AIDS Res Hum Retroviruses; 1997 Apr; 13(6):449-60. PubMed ID: 9100986 [TBL] [Abstract][Full Text] [Related]
53. Isomerization in the CDR2 of a monoclonal antibody: Binding analysis and factors that influence the isomerization rate. Dick LW; Qiu D; Wong RB; Cheng KC Biotechnol Bioeng; 2010 Feb; 105(3):515-23. PubMed ID: 19806678 [TBL] [Abstract][Full Text] [Related]
54. Structure-guided alterations of the gp41-directed HIV-1 broadly neutralizing antibody 2F5 reveal new properties regarding its neutralizing function. Guenaga J; Wyatt RT PLoS Pathog; 2012; 8(7):e1002806. PubMed ID: 22829767 [TBL] [Abstract][Full Text] [Related]
55. Mutation of Framework Residue H71 Results in Different Antibody Paratope States in Solution. Fernández-Quintero ML; Kroell KB; Hofer F; Riccabona JR; Liedl KR Front Immunol; 2021; 12():630034. PubMed ID: 33737932 [TBL] [Abstract][Full Text] [Related]
56. Characterizing the Diversity of the CDR-H3 Loop Conformational Ensembles in Relationship to Antibody Binding Properties. Fernández-Quintero ML; Loeffler JR; Kraml J; Kahler U; Kamenik AS; Liedl KR Front Immunol; 2018; 9():3065. PubMed ID: 30666252 [TBL] [Abstract][Full Text] [Related]
57. HIV-1 neutralizing antibodies elicited by the candidate CBD1 epitope vaccine react with the conserved caveolin-1 binding motif of viral glycoprotein gp41. Rey-Cuillé MA; Svab J; Benferhat R; Krust B; Briand JP; Muller S; Hovanessian AG J Pharm Pharmacol; 2006 Jun; 58(6):759-67. PubMed ID: 16734977 [TBL] [Abstract][Full Text] [Related]
58. Cell adhesion promoting peptide GVKGDKGNPGWPGAP from the collagen type IV triple helix: cis/trans proline-induced multiple 1H NMR conformations and evidence for a KG/PG multiple turn repeat motif in the all-trans proline state. Mayo KH; Parra-Diaz D; McCarthy JB; Chelberg M Biochemistry; 1991 Aug; 30(33):8251-67. PubMed ID: 1868097 [TBL] [Abstract][Full Text] [Related]
59. Structural basis for broad neutralization of HIV-1 through the molecular recognition of 10E8 helical epitope at the membrane interface. Rujas E; Caaveiro JM; Partida-Hanon A; Gulzar N; Morante K; Apellániz B; García-Porras M; Bruix M; Tsumoto K; Scott JK; Jiménez MÁ; Nieva JL Sci Rep; 2016 Dec; 6():38177. PubMed ID: 27905530 [TBL] [Abstract][Full Text] [Related]
60. Proline cis-trans isomerization and protein folding. Wedemeyer WJ; Welker E; Scheraga HA Biochemistry; 2002 Dec; 41(50):14637-44. PubMed ID: 12475212 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]